/Investor DB

AmorChem — 2022 Investments

1 investments dated 2022 · listed companies and verified rows first · show all

Inversagoinversago.comSeries A · Oct 2022 · $35Macquired by Novo Nordisk

Portfolio company acquired by Novo Nordisk for $1.1B USD.

Co-investorsadMare BioInnovationsGenesys CapitalJDRF T1D FundNew Enterprise Associates (NEA)Tarnagulla VenturesAmgen Ventures+2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.